Although negative results were obtained in some subgroups (subgroup 24 weeks in 6MWD, subgroup 24 weeks in LVEF, subgroups 8 weeks and 12 weeks in NT-proBNP, and subgroup 8 weeks in LVEDD), there still showed a trend toward improvement.
← all excerpts
Clinical efficacy and safety of adjunctive treatment of chronic ischemic heart failure with Qishen Yiqi dropping pills: a systematic review and meta-analysis.
1
—
—